Oops! It appears that you have disabled your Javascript. In order for you to see this page as it is meant to appear, we ask that you please re-enable your Javascript!
US lawsuit puts generic drug imports ...
Home  »  Community News  »  US lawsuit puts gene...
US lawsuit puts generic drug imports from India under scanner
Pharma News

A US class action lawsuit accusing India’s Ranbaxy of large-scale deception on its generic drug applications puts a question mark on drug imports from India, the largest supplier of generic drugs to the US.

The problem of lack of compliance with US Food and Drug Administration (FDA) guidance and gaps in protocol make it difficult to buy generics from pharma companies in India, which supply at least 40 percent of all generics in the US, according to biopharmadive.com.

The latest class action lawsuit against Ranbaxy, recently purchased by Sun Pharma in a $3.2 billion deal, was filed by US retailer Meijer in district court in Massachusetts.

Leave a reply

You must be logged in to post a comment.